期刊文献+

表皮生长因子受体和HER2在膀胱移行上皮细胞癌中的过度表达及其意义

Overexpression of Epidermal Growth Factor Receptor and HER2 in Transitional Epithelial Cell Carcinoma of Bladder and its Significance
下载PDF
导出
摘要 目的分析表皮生长因子受体和HER2在膀胱移行上皮细胞癌中的过度表达及意义。方法选择惠州市中心人民医院收治的100例膀胱移行上皮细胞癌患者(研究组)及健康膀胱组织的体检人群100例(参照组)进行观察,观察时间为2016年1月—2018年6月,针对两组观察对象实施免疫组织化学SP法检验,观察对比两组观察对象之间的指标差异。结果研究组100例膀胱移行上皮细胞癌患者检测后的表皮生长因子受体及HER2的过度表达率明显高于对照组健康人群(对照组无表达),两组相比差异有统计学有意义。研究组中表皮生长因子受体的过度表达在不同病理特征之间存在明显差异,HER2的过度表达与临床分期存在关系差异有统计学意义。结论表皮生长因子受体及HER2在膀胱移行上皮细胞癌中的过度表达及病情发展具有一定的相关性,两个指标均呈现过度表达状态表明患者预后较差。 Objective To analyze the overexpression and significance of epidermal growth factor receptor and HER2 in transitional epithelial cell carcinoma of bladder and its significance. Methods 100 patients with bladder transitional cell carcinoma(study group) and 100 healthy cases(control group)were observed. The observation time was from January,2016 to June,2018. Object implemen. tation of immunohistochemical SP method of inspection was observed,and index difference between the two groups was observed and compared. Results The overexpression rate of epidermal growth factor receptor and HER2 in 100 cases of transitional epithelial cell carcinoma of the bladder in the study group was significantly higher than that in the healthy population of the control group(no expres. sion was found in the control group),with statistically significant difference between the two groups. In addition,the overexpression of epidermal growth factor receptor in the study group was significantly different among different pathological characteristics,and the overexpression of HER2 was correlated with clinical stage,with statistically significanct difference. Conclusion Overexpression of epidermal growth factor receptor and HER2 in bladder transitional epithelial cell carcinoma(TCC)are correlated with the develop. ment of the disease. The overexpression of two index shows patients’poor prognosis.
作者 缪伟贤 MIAO Wei-xian(The First Area of Urinary,Huizhou Central People’s Hospital,Huizhou,Guangdong, 516001,China)
出处 《黑龙江医学》 2019年第3期197-198,207,共3页 Heilongjiang Medical Journal
关键词 表皮生长因子受体 HER2 膀胱移行上皮细胞癌 过度表达 Epidermal growth factor receptor HER2 Bladder transitional epithelial cell carcinoma Overexpression
  • 相关文献

参考文献5

二级参考文献62

  • 1林晓琳,程时丹,慎睿哲,王立夫.靶向于受体酪氨酸激酶的胃癌分子靶向治疗[J].胃肠病学和肝病学杂志,2009,18(11):974-979. 被引量:2
  • 2Bublil EM, Yarden Y, The EGF receptor family : spearheading a merger of signaling and therapeutics [ J ]. Curr Opin Cell Biol, 2007, 19 ( 2 ) : 124-134. DOI : 10.1016/j.ceb.2007.02.008.
  • 3Bethune G, Bethune D, Ridgway N, et al. Epidermal growth factor receptor ( EGFR ) in lung cancer: an overview and update [ J ]. J Thorac Dis, 2010, 2 ( 1 ) : 48-51. DOI:10.3978/j.issn.2072- 1439.2010.02.01.017.
  • 4Lee HI, Xu X, Choe G, et al. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas : Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study [J]. Lung Cancer, 2010, 68(3): 375-382. DOI:10.1016/j. lungean.2009.07.014.
  • 5Minami T, Kijima T, Satoshi K, et al. Overcoming ehemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody- dependent cell-mediated cytotoxicity and antiangiogenesis [ J ]. Sci Rep, 2013 10.1038/srep02669. VEGF-targeted 2669. DOI :.
  • 6Onn A, Correa AM, Gilcrease M, et al. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer [ J ]. Chn Cancer Res, 2004, 10 ( 1 pt 1 ) : 136-143. DOI: 10.1158/1078-0432.CCR-0373-3.
  • 7Cheng CM, Tsuneyama K, Matsui K, et al. Cytoplasmic expression of c-erbB2 in non-small cell lung cancers [ J ]. Virchows Arch, 2005, 446 ( 6 ) : 596-603. DOh 10.1007/s00428-005-1258-7.
  • 8Amin DN, Campbell MR, Moasser MM. The role of HER3,the unpretentious member of the HER family, in cancer biology and cancer therapeutics [ J ]. Semin Cell Dev Biol, 2010, 21 ( 9 ) : 944- 950. DOI : 10.1016/j.semcdb.2010.08.007.
  • 9Koutsopoulos AV, Mavroudis D, Damhaki KI, et al. Simultaneous expression ofc-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome [J]. Lung Cancer, 2007, 57 (2): 193-200. DOI:10.1016/j. lungcan.2007.03.009.
  • 10Rickman OB, Vohra PK, Sanyal B, et al. Analysis of erbB receptors in pulmonary carcinoid tumors [ J ]. Clin Cancer Res, 2009, 15 ( 10 ) : 3315-3324. DOI: 10.1158/1078-0432.CCR-08-2549.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部